Abbott Vascular to Distribute Roxwood Medical's Devices in the United States


July 25, 2017—Roxwood Medical Inc. announced it has entered into an exclusive agreement with Abbott Vascular for distribution of Roxwood products in the United States.

According to the company, Roxwood's anchoring catheters (CenterCross Ultra, MultiCross) and microcatheters (MicroCross) offer minimally invasive platforms for physicians to percutaneously treat chronic blockages by facilitating guidewire access across the blockage. The CenterCross Ultra and MultiCross catheters use an atraumatic nitinol anchoring mechanism to simplify guidewire access across arterial blockages. The MicroCross platform provides an ultra-low-profile microcatheter to access the most challenging coronary and peripheral anatomies with optimum guidewire support. Roxwood's products have regulatory clearance in major markets around the globe, noted the company.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.